{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/shingles/diagnosis/differential-diagnosis/","result":{"pageContext":{"chapter":{"id":"01bc96b7-ea05-59b9-963a-16b2722b9367","slug":"differential-diagnosis","fullItemName":"Differential diagnosis","depth":2,"htmlHeader":"<!-- begin field d902e79d-1aa5-4b57-83f4-a6b200f02fa2 --><h2>What else might it be?</h2><!-- end field d902e79d-1aa5-4b57-83f4-a6b200f02fa2 -->","summary":"","htmlStringContent":"<!-- begin item 76467b4e-5400-4077-80a5-a6b200f02f80 --><!-- begin field 9d4709f9-4fe7-4f20-b661-a6b200f02fa2 --><ul><li><strong>Differential diagnoses of shingles include:</strong><ul><li>Herpes simplex virus (HSV) infection — this can also present with a unilateral, red, maculopapular, vesicular rash and acute pain. Features which are more likely to indicate HSV infection include multiple recurrences (around the mouth or genital areas) and lack of chronic pain. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/herpes-simplex-genital/\">Herpes simplex - genital</a> and <a class=\"topic-reference external-reference\" href=\"/topics/herpes-simplex-oral/\">Herpes simplex - oral</a> for more information.</li><li>Candidal skin infection — the appearance of the skin is variable, depending on the affected area. Soreness and itching is usual. Thin-walled pustules with a red base may be present. Scales may accumulate, producing a white-yellow, curd-like substance over the infected area. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/candida-skin/\">Candida - skin</a> for more information.</li><li>Contact dermatitis — localized rash or irritation of the skin caused by contact with a foreign substance. The pain and the rash usually occur simultaneously. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/dermatitis-contact/\">Dermatitis - contact</a> for more information.</li><li>Folliculitis — a superficial infection of the hair follicles, which develop into small inflammatory papules or pustules. </li><li>Impetigo — presents with vesicles, which can rupture and crust. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/impetigo/\">Impetigo</a> for more information.</li><li>Insect bite or sting — there may be local symptoms (such as pain, swelling, and erythema) and symptoms that may indicate a systemic reaction (such as urticaria, rhinitis, wheezing, abdominal pain, vomiting, and dizziness). See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/insect-bites-stings/\">Insect bites and stings</a> for more information.</li><li>Scabies — an intensely itchy skin infestation characterized by symmetric erythematous papules, often excoriated, seen in a characteristic pattern. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/scabies/\">Scabies</a> for more information.</li><li>Urticaria — a superficial swelling of the skin (epidermis and mucous membranes) that results in a red, raised, itchy rash. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/urticaria/\">Urticaria</a> for more information.</li></ul></li><li><strong>Differential diagnoses of <a class=\"topic-reference internal-reference\" href=\"/topics/shingles/background-information/complications/\">herpes zoster ophthalmicus</a> include:</strong><ul><li>Acute angle closure glaucoma — characterized by periorbital pain, blurred vision, and headache. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/glaucoma/\">Glaucoma</a> for more information.</li><li>HSV ocular infections — characterized by eye pain, blurred vision, an acute red eye, and crops of vesicles, ulcers, or pustules along the lid margin or periocular skin. HSV ocular infections can cause retinitis, iritis or uveitis, keratitis, conjunctivitis, blepharitis, and periocular dermatitis. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/herpes-simplex-ocular/\">Herpes simplex - ocular</a> for more information.</li><li>Trigeminal neuralgia — characterized by intense, stabbing, electric shock-like pain in the areas of the face innervated by the trigeminal nerve. There may be an obvious trigger area for the pain. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/trigeminal-neuralgia/\">Trigeminal neuralgia</a> for more information.</li><li>Ulcerative keratitis — symptoms depend on the cause. The person may present with pain and redness in the affected eye, with visual changes depending on the ulcer location.</li></ul></li><li><strong>The prodromal pain of shingles can often mimic other conditions, depending on the site of infection, including: </strong><ul><li>Acute appendicitis — characterized by pain in the right lower abdominal quadrant. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/appendicitis/\">Appendicitis</a> for more information.</li><li>Cholecystitis — characterized by pain in the right upper quadrant of the abdomen, accompanied with nausea, vomiting, and fever. On examination the person may have Murphy's sign. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/cholecystitis-acute/\">Cholecystitis - acute</a> for more information.</li><li>Migraine — characterized by attacks of moderate or severe headache and associated symptoms, such as photophobia, phonophobia, nausea, and vomiting. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/migraine/\">Migraine</a> for more information.</li><li>Renal calculi — characterized by severe colicky pain and inability to lie still, and flank pain on examination. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/renal-or-ureteric-colic-acute/\">Renal or ureteric colic - acute</a> for more information.</li></ul></li></ul><!-- end field 9d4709f9-4fe7-4f20-b661-a6b200f02fa2 --><!-- end item 76467b4e-5400-4077-80a5-a6b200f02f80 -->","topic":{"id":"012e484d-8c14-5168-bb5d-e5acb7d4571a","topicId":"2969a8ac-cb7f-4569-be79-822e6009081a","topicName":"Shingles","slug":"shingles","lastRevised":"Last revised in October 2020","chapters":[{"id":"eeb1b918-6c05-5340-b348-ce2809516623","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"8ad8b1b2-36bb-5262-ab5a-05763d6e4c7d","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"b1aed669-8481-5315-ab58-4bb18606e360","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"8fef2c66-91dc-57c6-8cd3-4e4eff8d7727","slug":"changes","fullItemName":"Changes"},{"id":"ea603e45-ec07-5201-a182-ebef4c48ef6b","slug":"update","fullItemName":"Update"}]},{"id":"81feec28-1a5d-5a24-9c52-bee13821b03b","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"bb672f83-c2bd-5dd7-9934-78f09729db48","slug":"goals","fullItemName":"Goals"},{"id":"2036bd3f-37bc-5cea-887d-55c3fc68c7cf","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"cc04b460-a0d8-5e8d-b8d0-c044947b4bd6","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"ee3573cb-38d5-5d4c-9c9d-cd274242d964","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"52999d3b-9cce-59c5-b588-1f7ad7de33e2","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"40a91fd6-3c01-5713-85ad-0a5c4379eab9","slug":"nice-quality-standards","fullItemName":"NICE Quality standards"}]},{"id":"04a0af22-814d-5b14-b28c-7916f1772a4d","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"097dfec6-754a-54a8-9d96-44e1c5704248","slug":"definition","fullItemName":"Definition"},{"id":"f20034b1-ae3e-505b-ac16-3e11f2a6653e","slug":"prevalence","fullItemName":"Prevalence"},{"id":"e92f0243-b1ac-50d9-a31a-a07a4c61c5a7","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"b6f8c581-b332-5d26-ba45-ccfb7189a387","slug":"complications","fullItemName":"Complications"},{"id":"012c8f32-e9cf-5897-a695-4c21cd28ae5d","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"81f3feff-d640-5ee2-83fa-af1a4e8b586a","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"56b89dcf-d466-50f3-a8a0-3a9477ef3362","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"01bc96b7-ea05-59b9-963a-16b2722b9367","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"acd9aec2-87d6-5084-bd3a-5c0b1d164ab4","fullItemName":"Management","slug":"management","subChapters":[{"id":"9872f447-6f59-502d-b6cb-a0fae6d2c085","slug":"management","fullItemName":"Scenario: Management"},{"id":"9ecdcc36-4fec-5b60-aa42-2032f2c406a4","slug":"prevention","fullItemName":"Scenario: Prevention"}]},{"id":"929d18e1-e1f0-5d08-8c55-d289b349a9fd","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"4445c1da-4f7a-5f12-a909-0112bbd72453","slug":"antiviral-drugs","fullItemName":"Antiviral drugs"},{"id":"1223613b-f5a6-5da6-a311-275f5d6181b2","slug":"zostavax","fullItemName":"Zostavax"}]},{"id":"67979756-a00f-5f10-a93e-81509b35e1a8","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"625749c2-4e09-57ba-bdee-cd206d8b02d5","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"377ce207-6229-5548-aef7-a637f176a94e","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"19ac0831-d4e2-52c3-b127-e78b1f26fb6f","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d46d7aff-a113-50d5-afa1-3310aad844d7","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"d23205e9-41c9-5c70-a9f9-5ce3cfae633a","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"cf98894b-c083-59fd-8150-f390845960f1","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a52b727c-ba28-5973-9e3c-e4882a883593","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"81f3feff-d640-5ee2-83fa-af1a4e8b586a","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"533cfa34-9bdf-5b88-95d9-40b24069c662","slug":"basis-for-recommendation-e9d","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 3fd2a716-149c-4b83-89b9-a6bf0109ecce --><h3>Basis for recommendation</h3><!-- end field 3fd2a716-149c-4b83-89b9-a6bf0109ecce -->","summary":null,"htmlStringContent":"<!-- begin item e9dcba5c-69c5-451e-9a0c-a6bf0109ebb3 --><!-- begin field 3b8eb306-6dfa-4e11-93ae-a6bf0109ecce --><p>The information on differential diagnosis is taken from the <em>European consensus‐based (S2k) Guideline on the Management of Herpes Zoster – guided by the European Dermatology Forum (EDF) in cooperation with the European Academy of Dermatology and Venereology (EADV), Part 1: Diagnosis</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/shingles/references/\">Werner, 2017a</a>], the Centers for Disease Control and Prevention (CDC) guideline <em>Shingles (Herpes Zoster) </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/shingles/references/\">CDC, 2019</a>], and review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/shingles/references/\">Cohen, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/shingles/references/\">Schmader, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/shingles/references/\">Saguil, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/shingles/references/\">BMJ, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/shingles/references/\">Le, 2019</a>].</p><!-- end field 3b8eb306-6dfa-4e11-93ae-a6bf0109ecce --><!-- end item e9dcba5c-69c5-451e-9a0c-a6bf0109ebb3 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}